Glucokinase has a very high flux control coefficient (greater than unity) on glycogen synthesis from glucose in hepatocytes (Agius et al., J. Biol. Chem. 271, 30479 -30486, 1996). Hepatic glucokinase is inhibited by a 68-kDa glucokinase regulatory protein (GKRP) that is expressed in molar excess. To establish the relative control exerted by glucokinase and GKRP, we applied metabolic control analysis to determine the flux control coefficient of GKRP on glucose metabolism in hepatocytes. Adenovirus-mediated overexpression of GKRP (by up to 2-fold above endogenous levels) increased glucokinase binding and inhibited glucose phosphorylation, glycolysis, and glycogen synthesis over a wide range of concentrations of glucose and sorbitol. It decreased the affinity of glucokinase translocation for glucose and increased the control coefficient of glucokinase on glycogen synthesis. GKRP had a negative control coefficient of glycogen synthesis that is slightly greater than unity (؊1.2) and a control coefficient on glycolysis of ؊0.5. The control coefficient of GKRP on glycogen synthesis decreased with increasing glucokinase overexpression (4-fold) at elevated glucose concentration (35 mM), which favors dissociation of glucokinase from GKRP, but not at 7.5 mM glucose. Under the latter conditions, glucokinase and GKRP have large and inverse control coefficients on glycogen synthesis, suggesting that a large component of the positive control coefficient of glucokinase is counterbalanced by the negative coefficient of GKRP. It is concluded that glucokinase and GKRP exert reciprocal control; therefore, mutations in GKRP affecting the expression or function of the protein may impact the phenotype even in the heterozygote state, similar to glucokinase mutations in maturity onset diabetes of the young type 2. Our results show that the mechanism comprising glucokinase and GKRP confers a markedly extended responsiveness and sensitivity to changes in glucose concentration on the hepatocyte.Glucokinase (hexokinase IV) is the predominant glucose phosphorylating enzyme in hepatocytes and insulin-secreting and glucagon-secreting cells of the pancreas and has a major role in the control of blood glucose homeostasis (1, 2). Its importance has been confirmed by the finding that mutations in its gene cause a form of diabetes known as maturity onset diabetes of the young type 2 (MODY-2), 1 which is characterized by mild hyperglycemia, decreased glucose-induced insulin secretion, impaired hepatic glycogen storage, and dominant inheritance (3), and by studies on hepatic glucokinase knockout mice (4). Hepatic glucokinase is Regulated by a 68-kDa regulatory protein (GKRP) (5, 6). Expression of GKRP during development precedes expression of glucokinase (7), and no physiological situations are known in which hepatic glucokinase is expressed in the absence of its regulatory protein. GKRP is located mainly in the nucleus of hepatocytes, whereas glucokinase translocates between the nucleus and the cytoplasm (8). Glucokinase binds GKRP in the nucleus at...